AlzeCure to Present at International Scientific Conference

STOCKHOLM, March 25, 2019 /PRNewswire/ — AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that it will have two presentations at AD/PD 2019, the 14th International Conference on Alzheimer’s & Parkinson’s Diseases, March 26-31, in Lisbon, Portugal. Märta Dahlström, who is the lead author of the study, will give her oral presentation on March 27, at 2pm WET (3pm CET).The title of it is: AC-25793, A Positive Modulator of Neurotrophin Signaling, Attenuates Scopolamine-Induced Memory Impairment and Reduces Depression-Like Symptoms in Mice. “In this study, we have within our NeuroRestore platform developed new small molecules that can enhance NGF/TrkA and ...

Gepostet in der Kategorie Wirtschaft (Anzahl der ansichten:) 8

Ähnlich Nachrichten